Raza Azra, Assal Amer, Ali Abdullah M, Jurcic Joseph G
Division of Hematology/Oncology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, USA.
Herbert Irving Comprehensive Cancer Center, Columbia University, USA.
Leuk Res Rep. 2020 Apr 20;13:100201. doi: 10.1016/j.lrr.2020.100201. eCollection 2020.
The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusions, and chemotherapy, preferably selecting self-administered medications and visits by home healthcare workers, are employed to minimize exposure of our high-risk population of patients to the virus. The unique challenges of transplants during the pandemic and the consequences of an abrupt halt in all non-essential research activities are described. Not all the changes forced by COVID-19 are detrimental.
新型冠状病毒肺炎（COVID-19）已彻底改变了骨髓增生异常综合征（MDS）和急性髓系白血病（AML）患者的治疗方式，在疫情中心纽约市尤为如此。在此，我们总结了如何利用远程医疗、虚拟问诊、延迟输血和化疗（最好选择患者自行给药以及由家庭医护人员上门问诊），以尽量减少我们的高危患者群体接触该病毒。文中还描述了疫情期间移植面临的独特挑战以及所有非必要研究活动突然停止的后果。并非COVID-19带来的所有变化都是有害的。
